These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38722455)

  • 21. Development of a Multiplexed Assay for Detection of
    Abeijon C; Alves F; Monnerat S; Wasunna M; Mbui J; Viana AG; Bueno LL; Siqueira WF; Carvalho SG; Agrawal N; Fujiwara R; Sundar S; Campos-Neto A
    J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30787142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of synergy between host and pathogen-directed therapies against intracellular Leishmania donovani.
    Zahid MSH; Johnson MM; Tokarski RJ; Satoskar AR; Fuchs JR; Bachelder EM; Ainslie KM
    Int J Parasitol Drugs Drug Resist; 2019 Aug; 10():125-132. PubMed ID: 31493763
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Tadele M; Abay SM; Makonnen E; Hailu A
    Drug Des Devel Ther; 2020; 14():1307-1317. PubMed ID: 32280200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro anti-leishmanial efficacy of potato tuber extract (PTEx): leishmanial serine protease(s) as putative target.
    Paik D; Das P; De T; Chakraborti T
    Exp Parasitol; 2014 Nov; 146():11-9. PubMed ID: 25128800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Modeling and Virtual Screening Approach to Discover Potential Antileishmanial Inhibitors Against Ornithine Decarboxylase.
    Pandey RK; Prajapati P; Goyal S; Grover A; Prajapati VK
    Comb Chem High Throughput Screen; 2016; 19(10):813-823. PubMed ID: 27604958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring actinomycetes natural products to identify potential multi-target inhibitors against
    Singh S; Prajapati VK
    3 Biotech; 2022 Sep; 12(9):235. PubMed ID: 35999912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First report of cutaneous leishmaniasis caused by Leishmania donovani in Ethiopia.
    Amare GA; Mekonnen GG; Kassa M; Addisu A; Kendie DA; Tegegne B; Abera A; Tadesse D; Getahun S; Wondmagegn YM; Merdekios B; Asres MS; van Griensven J; Van der Auwera G; van Henten S; Pareyn M
    Parasit Vectors; 2023 Dec; 16(1):457. PubMed ID: 38104111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of Leishmania donovani topoisomerase IB selective inhibitors by targeting protein-protein interactions between the large and small subunits.
    Lee H; Baek KH; Phan TN; Park IS; Lee S; Kim J; No JH
    Biochem Biophys Res Commun; 2021 Sep; 569():193-198. PubMed ID: 34256188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An immunoinformatic approach driven by experimental proteomics: in silico design of a subunit candidate vaccine targeting secretory proteins of Leishmania donovani amastigotes.
    Khan MAA; Ami JQ; Faisal K; Chowdhury R; Ghosh P; Hossain F; Abd El Wahed A; Mondal D
    Parasit Vectors; 2020 Apr; 13(1):196. PubMed ID: 32295617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptide-mediated leishmaniasis management strategy: Tachyplesin emerges as an effective anti-leishmanial peptide against Leishmania donovani.
    Kumar V; Chugh A
    Biochim Biophys Acta Biomembr; 2021 Aug; 1863(8):183629. PubMed ID: 33933430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leishmania donovani Aurora kinase: A promising therapeutic target against visceral leishmaniasis.
    Chhajer R; Bhattacharyya A; Didwania N; Shadab M; Das N; Palit P; Vaidya T; Ali N
    Biochim Biophys Acta; 2016 Sep; 1860(9):1973-88. PubMed ID: 27288586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular docking and structure-based virtual screening studies of potential drug target, CAAX prenyl proteases, of Leishmania donovani.
    Singh S; Vijaya Prabhu S; Suryanarayanan V; Bhardwaj R; Singh SK; Dubey VK
    J Biomol Struct Dyn; 2016 Nov; 34(11):2367-86. PubMed ID: 26551589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic Potential of Quercetin-Loaded Nanoemulsion against Experimental Visceral Leishmaniasis:
    Das SS; Dubey AK; Verma PRP; Singh SK; Singh SK
    Mol Pharm; 2022 Sep; 19(9):3367-3384. PubMed ID: 35980291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue Specific Dual RNA-Seq Defines Host-Parasite Interplay in Murine Visceral Leishmaniasis Caused by Leishmania donovani and Leishmania infantum.
    Forrester S; Goundry A; Dias BT; Leal-Calvo T; Moraes MO; Kaye PM; Mottram JC; Lima APCA
    Microbiol Spectr; 2022 Apr; 10(2):e0067922. PubMed ID: 35384718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Modeling, Virtual Screening, and Molecular Dynamics for
    Teles HR; Valli M; Ferreira LLG; Andricopulo AD
    J Phys Chem B; 2022 Dec; 126(51):10834-10843. PubMed ID: 36534784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repurposing of FDA-approved drugs as inhibitors of sterol C-24 methyltransferase of Leishmania donovani to fight against leishmaniasis.
    Tabrez S; Rahman F; Ali R; Muhammad F; Alshehri BM; Alaidarous MA; Banawas S; Dukhyil AAB; Rub A
    Drug Dev Res; 2021 Dec; 82(8):1154-1161. PubMed ID: 33929761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo experiments demonstrate the potent antileishmanial efficacy of repurposed suramin in visceral leishmaniasis.
    Khanra S; Juin SK; Jawed JJ; Ghosh S; Dutta S; Nabi SA; Dash J; Dasgupta D; Majumdar S; Banerjee R
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008575. PubMed ID: 32866156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leishmania donovani: dynamics of L. donovani evasion of innate immune cell attack due to malnutrition in visceral leishmaniasis.
    Kumar V; Bimal S; Singh SK; Chaudhary R; Das S; Lal C; Pandey K; Das VR; Das P
    Nutrition; 2014 Apr; 30(4):449-58. PubMed ID: 24607302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rationally Designed Minimal Bioactive Domains of AS-48 Bacteriocin Homologs Possess Potent Antileishmanial Properties.
    Corman HN; Ross JN; Fields FR; Shoue DA; McDowell MA; Lee SW
    Microbiol Spectr; 2022 Dec; 10(6):e0265822. PubMed ID: 36342284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of two natural compound inhibitors of Leishmania donovani Spermidine Synthase (SpdS) through molecular docking and dynamic studies.
    V M V; Dubey VK; Ponnuraj K
    J Biomol Struct Dyn; 2018 Aug; 36(10):2678-2693. PubMed ID: 28797195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.